{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:24:07Z","timestamp":1788539047827,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.yexcr.2026.115141","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:14:28Z","timestamp":1785168868000},"page":"115141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neddylation cooperates with multiple phosphorylation to enhance FGFR1 stability and drive breast cancer progression"],"prefix":"10.1016","volume":"462","author":[{"given":"Yongjun","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezhou","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5959-0402","authenticated-orcid":false,"given":"Junfang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2026.115141_bib1","first-page":"10","article-title":"Cancer statistics","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.yexcr.2026.115141_bib2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.yexcr.2026.115141_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduction Targeted Ther."},{"key":"10.1016\/j.yexcr.2026.115141_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.962561","article-title":"Multi-organ FGF21-FGFR1 signaling in metabolic health and disease","volume":"9","author":"Kaur","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.yexcr.2026.115141_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155962","article-title":"Dihydroartemisinin inhibited vasculogenic mimicry in gastric cancer through the FGF2\/FGFR1 signaling pathway","volume":"134","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.yexcr.2026.115141_bib6","doi-asserted-by":"crossref","first-page":"6695","DOI":"10.7150\/jca.49269","article-title":"Landscape of FGF\/FGFR Alterations in 12,372 Chinese cancer patients","volume":"11","author":"Zuo","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.yexcr.2026.115141_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.367","article-title":"FGFR families: biological functions and therapeutic interventions in tumors","volume":"4","author":"Liu","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.yexcr.2026.115141_bib8","article-title":"The 8p11 myeloproliferative syndrome: genotypic and phenotypic classification and targeted therapy","volume":"12","author":"Li","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexcr.2026.115141_bib9","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.1158\/1078-0432.CCR-06-1164","article-title":"FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas","volume":"12","author":"Reis-Filho","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2026.115141_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cells7070076","article-title":"Current status of fibroblast growth factor receptor-targeted therapies in breast cancer","volume":"7","author":"Sobhani","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.yexcr.2026.115141_bib11","article-title":"Post\u2010translational modifications in diabetic cardiomyopathy","volume":"28","author":"Li","year":"2024","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.yexcr.2026.115141_bib12","article-title":"Control of protein stability by post-translational modifications","volume":"14","author":"Lee","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2026.115141_bib13","doi-asserted-by":"crossref","first-page":"5349","DOI":"10.1021\/acs.biomac.1c01280","article-title":"Intrinsically fluorescent Oligomeric cytotoxic conjugates toxic for FGFR1-Overproducing cancers","volume":"22","author":"Por\u0119bska","year":"2021","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.yexcr.2026.115141_bib14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev-cellbio-100617-062802","article-title":"Principles of ubiquitin-dependent signaling","volume":"34","author":"Oh","year":"2018","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.yexcr.2026.115141_bib15","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.molcel.2024.01.024","article-title":"UFL1 ablation in T cells suppresses PD-1 UFMylation to enhance anti-tumor immunity","volume":"84","author":"He","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.yexcr.2026.115141_bib16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrc2780","article-title":"Fibroblast growth factor signalling: from development to cancer","volume":"10","author":"Turner","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexcr.2026.115141_bib17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.7150\/ijbs.75852","article-title":"Neddylation of HER2 inhibits its protein degradation and promotes breast cancer progression","volume":"19","author":"Xia","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.yexcr.2026.115141_bib18","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1158\/0008-5472.CAN-10-2122","article-title":"Inhibition of NEDD8-Activating enzyme induces rereplication and apoptosis in human tumor cells consistent with deregulating CDT1 turnover","volume":"71","author":"Milhollen","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2026.115141_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-020-00226-3","article-title":"NEDD8-conjugating enzyme UBC12 as a novel therapeutic target in esophageal squamous cell carcinoma","volume":"5","author":"Wang","year":"2020","journal-title":"Signal Transduction Targeted Ther."},{"key":"10.1016\/j.yexcr.2026.115141_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-024-01800-9","article-title":"Protein neddylation and its role in health and diseases","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduction Targeted Ther."},{"key":"10.1016\/j.yexcr.2026.115141_bib21","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.7150\/thno.78876","article-title":"Targeting cullin neddylation for cancer and fibrotic diseases","volume":"13","author":"He","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.yexcr.2026.115141_bib22","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nature07884","article-title":"An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer","volume":"458","author":"Soucy","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2026.115141_bib23","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1158\/0008-5472.CAN-24-3217","article-title":"A genome-wide synthetic lethal screen identifies spermidine synthase as a target to enhance erdafitinib efficacy in FGFR-Mutant bladder cancer","volume":"85","author":"Yu","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2026.115141_bib24","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","article-title":"20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years","volume":"377","author":"Pan","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexcr.2026.115141_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13045-024-01558-1","article-title":"Targeting FGFR for cancer therapy","volume":"17","author":"Zhang","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.yexcr.2026.115141_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2025.108844","article-title":"Fibroblast growth factor receptor signaling in metabolic dysfunction-associated fatty liver disease: pathogenesis and therapeutic targets","volume":"269","author":"Chu","year":"2025","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.yexcr.2026.115141_bib27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1158\/1078-0432.CCR-14-3212","article-title":"The FGFR landscape in cancer: analysis of 4,853 tumors by next-generation sequencing","volume":"22","author":"Helsten","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2026.115141_bib28","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/s41556-021-00781-z","article-title":"FGFR-inhibitor-mediated dismissal of SWI\/SNF complexes from YAP-dependent enhancers induces adaptive therapeutic resistance","volume":"23","author":"Li","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.yexcr.2026.115141_bib29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41392-020-00222-7","article-title":"FGF\/FGFR signaling in health and disease","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.yexcr.2026.115141_bib30","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0092-8674(00)80051-3","article-title":"Structural basis for FGF receptor dimerization and activation","volume":"98","author":"Plotnikov","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2026.115141_bib31","article-title":"FGFR signaling and endocrine resistance in breast cancer: challenges for the clinical development of FGFR inhibitors","volume":"1876","author":"Servetto","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.yexcr.2026.115141_bib32","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.1158\/1078-0432.CCR-10-2727","article-title":"FGFR signaling promotes the growth of triple-negative and basal-like breast cancer cell lines both in vitro and in vivo","volume":"17","author":"Sharpe","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2026.115141_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.261","article-title":"Protein posttranslational modifications in health and diseases: functions, regulatory mechanisms, and therapeutic implications","volume":"4","author":"Zhong","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.yexcr.2026.115141_bib34","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.molcel.2012.12.002","article-title":"c-Cbl-mediated neddylation antagonizes ubiquitination and degradation of the TGF-\u03b2 type II receptor","volume":"49","author":"Zuo","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.yexcr.2026.115141_bib35","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41568-023-00633-y","article-title":"Deubiquitinases in cancer","volume":"23","author":"Dewson","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexcr.2026.115141_bib36","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2202631119","article-title":"FGFR1 SUMOylation coordinates endothelial angiogenic signaling in angiogenesis","volume":"119","author":"Zhu","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.yexcr.2026.115141_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.101140","article-title":"Inhibiting neddylation: a new strategy for tumor therapy","volume":"15","author":"Sun","year":"2025","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.yexcr.2026.115141_bib38","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S1097-2765(02)00784-0","article-title":"CAND1 binds to unneddylated CUL1 and regulates the formation of SCF ubiquitin E3 ligase complex","volume":"10","author":"Zheng","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.yexcr.2026.115141_bib39","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.apsb.2020.09.007","article-title":"Phosphorylation regulates cullin-based ubiquitination in tumorigenesis","volume":"11","author":"Chen","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.yexcr.2026.115141_bib40","article-title":"Neddylation modification stabilizes LC3B by antagonizing its ubiquitin-mediated degradation and promoting autophagy in skin","volume":"122","author":"Xu","year":"2025","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.yexcr.2026.115141_bib41","first-page":"2238","article-title":"RNF168-mediated H2A neddylation antagonizes ubiquitylation of H2A and regulates DNA damage repair","volume":"127","author":"Li","year":"2014","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.yexcr.2026.115141_bib42","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/s41594-024-01257-y","article-title":"Noncanonical assembly, neddylation and chimeric cullin-RING\/RBR ubiquitylation by the 1.8 MDa CUL9 E3 ligase complex","volume":"31","author":"Horn-Ghetko","year":"2024","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.yexcr.2026.115141_bib43","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.annonc.2022.03.006","article-title":"Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: safety and patient-reported outcomes from the monarchE study","volume":"33","author":"Rugo","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.yexcr.2026.115141_bib44","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1038\/emboj.2011.234","article-title":"Nedd4-1 binds and ubiquitylates activated FGFR1 to control its endocytosis and function","volume":"30","author":"Persaud","year":"2011","journal-title":"EMBO J."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482726002582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482726002582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:09:53Z","timestamp":1788538193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482726002582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0014482726002582"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.115141","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neddylation cooperates with multiple phosphorylation to enhance FGFR1 stability and drive breast cancer progression","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.115141","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115141"}}